Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.54 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.51 |
| ▸ | ADRA2B | P18089 | 3/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.51 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.51 |
| ▸ | DRD1 | P21728 | 1/20 | 0.51 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.51 |
| ▸ | HTR2A | P28223 | 1/20 | 0.51 |
| ▸ | HTR2C | P28335 | 1/20 | 0.51 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.51 |
| ▸ | HRH1 | P35367 | 1/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.51 |
| ▸ | HTR2B | P41595 | 1/20 | 0.51 |
| ▸ | HTR6 | P50406 | 1/20 | 0.51 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4599895 | 0.98 | KDM4E (0.53) | TAAR1ADRA2AADRA2BCYP1A2CHRM2 | |
| SCHEMBL2376358 | 0.88 | TAAR1 (0.55) | TAAR1ADRA2AADRA2BCYP1A2CHRM2 | |
| Hydrochloric Acid SCHEMBL9471912 | 0.86 | TAAR1 (0.53) | TAAR1ADRA2AADRA2BCYP1A2CHRM2 | |
| SCHEMBL9799324 | 0.86 | TAAR1 (0.53) | TAAR1ADRA2AADRA2BCYP1A2CHRM2 | |
| SCHEMBL1304013 | 0.82 | — | — | |
| SCHEMBL10937071 | 0.82 | DRD2 (0.49) | TAAR1ADRA2AADRA2BCYP1A2CHRM2 | |
| SCHEMBL21034335 | 0.80 | DRD2 (0.55) | TAAR1ADRA2AADRA2BCHRM1DRD1 | |
| Hydrochloric Acid SCHEMBL28582399 | 0.80 | HPGD (0.53) | TAAR1ADRA2AADRA2BCYP1A2CHRM2 | |
| SCHEMBL1780110 | 0.79 | DRD2 (0.58) | TAAR1ADRA2AADRA2BCYP1A2CHRM2 | |
| Hydrochloric Acid SCHEMBL11064048 | 0.79 | TAAR1 (0.46) | TAAR1ADRA2AADRA2BCYP1A2CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250127728-A1 | Constrained Ionizable Cationic Lipids and Lipid Nanoparticles | CAPSTAN THERAPEUTICS, INC. | 2025-04-24 | — | — | US | disclosed |
| CN-110054865-B | Resin composition | 味之素株式会社 | 2024-05-14 | — | — | CN | disclosed |
| CN-117957068-A | Method for discharging resin composition, method for manufacturing electronic component, and electronic component | 纳美仕有限公司 | 2024-04-30 | — | — | CN | disclosed |
| CN-117957270-A | Resin composition for injection dispensing, adhesive for electronic component, cured product thereof, and electronic component | 纳美仕有限公司 | 2024-04-30 | — | — | CN | disclosed |
| CN-117940488-A | Resin composition, adhesive for electronic component, cured product thereof, and electronic component | 纳美仕有限公司 | 2024-04-26 | — | — | CN | disclosed |
| EP-2963076-B9 | HYDROPHILIC BLOCK COPOLYMERS AND MEMBRANES PREPARED THEREFROM | PALL CORP (US) | 2023-12-06 | — | — | EP | disclosed |
| CN-114636768-B | Detection method for thiamethoxam residues in jasmine flowers | 广西-东盟食品检验检测中心 | 2023-11-07 | — | — | CN | disclosed |
| EP-2963076-B1 | HYDROPHILIC BLOCK COPOLYMERS AND MEMBRANES PREPARED THEREFROM | PALL CORP (US) | 2023-09-13 | — | — | EP | disclosed |
| CN-116715939-A | Curable resin composition, adhesive, and adhesive method | 味之素株式会社 | 2023-09-08 | — | — | CN | disclosed |
| CN-116063978-A | Curable composition | 味之素株式会社 | 2023-05-05 | — | — | CN | disclosed |
| WO-1999034839-A1 | METHODS FOR QUENCHING PATHOGEN INACTIVATORS IN BIOLOGICAL MATERIALS | CERUS CORPORATION (US) | 1999-07-15 | — | — | WO | disclosed |
| WO-1999034914-A1 | BATCH DEVICES FOR THE REDUCTION OF COMPOUNDS FROM BIOLOGICAL COMPOSITIONS CONTAINING CELLS AND METHODS OF USE | CERUS CORPORATION (US) | 1999-07-15 | — | — | WO | disclosed |
| WO-1999034915-A1 | FLOW DEVICES FOR THE REDUCTION OF COMPOUNDS FROM BIOLOGICAL COMPOSITIONS AND METHODS OF USE | CERUS CORPORATION (US) | 1999-07-15 | — | — | WO | disclosed |
| WO-1998030327-A1 | METHODS AND DEVICES FOR THE REDUCTION OF SMALL ORGANIC COMPOUNDS FROM BLOOD PRODUCTS | CERUS CORPORATION (US) | 1998-07-16 | — | — | WO | disclosed |
| EP-0226896-B1 | LANKACIDIN DERIVATIVES AND PRODUCTION THEREOF | Takeda Chemical Industries, Ltd. (JP) | 1993-09-15 | — | — | EP | disclosed |
| EP-0362137-A2 | Molded polymers with hydrophilic surfaces, and process for making them | CIBA-GEIGY AG (CH) | 1990-04-04 | — | — | EP | disclosed |
| US-4914206-A | ANTIBIOTICS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1990-04-03 | — | — | US | disclosed |
| EP-0289262-A2 | Omega-quaternary ammonium alkyl esters and thioesters of acidic nonsteroidal antiinflammatory drugs | SYNTEX PHARMACEUTICALS INTERNATIONAL LIMITED (BM) | 1988-11-02 | — | — | EP | disclosed |
| EP-0226896-A2 | Lankacidin derivatives and production thereof | Takeda Chemical Industries, Ltd. (JP) | 1987-07-01 | — | — | EP | disclosed |
| US-4506007-A | TREATED WITH N,N'-DISUBSTITUTED-S-(DIMETHYLAMINO) ETHYTL)-ISOTHIOUREAS | FUJI PHOTO FILM CO., LTD. (JP) | 1985-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250127728-A1 | Constrained Ionizable Cationic Lipids and Lipid Nanoparticles | LNPEP, PLTP, SARNP | TAAR1 2735/4885ADRA2A 4762/4885ADRA2B 4747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.